| Data | Hora | Fonte | Título | Código | Companhia |
| 29/03/2019 | 09:25 | Edgar (US Regulatory) | Proxy Statement (definitive) (def 14a) | NASDAQ:PTIE | Pain Therapeutics, Inc. (MM) |
| 29/03/2019 | 07:09 | Edgar (US Regulatory) | Annual Report (10-k) | NASDAQ:PTIE | Pain Therapeutics, Inc. (MM) |
| 27/03/2019 | 16:04 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:PTIE | Pain Therapeutics, Inc. (MM) |
| 27/03/2019 | 09:30 | GlobeNewswire Inc. | Pain Therapeutics Announces Name Change to Cassava Sciences, Inc. | NASDAQ:PTIE | Pain Therapeutics, Inc. (MM) |
| 25/03/2019 | 09:30 | GlobeNewswire Inc. | Pain Therapeutics Reports 2018 Financial Results and Corporate Update | NASDAQ:PTIE | Pain Therapeutics, Inc. (MM) |
| 04/03/2019 | 16:56 | Edgar (US Regulatory) | Statement of Ownership (sc 13g) | NASDAQ:PTIE | Pain Therapeutics, Inc. (MM) |
| 14/02/2019 | 18:04 | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:PTIE | Pain Therapeutics, Inc. (MM) |
| 05/02/2019 | 11:00 | GlobeNewswire Inc. | Pain Therapeutics Announces Feedback from Recent Meeting with FDA on REMOXY | NASDAQ:PTIE | Pain Therapeutics, Inc. (MM) |
| 31/01/2019 | 09:02 | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:PTIE | Pain Therapeutics, Inc. (MM) |
| 17/01/2019 | 12:00 | GlobeNewswire Inc. | Pain Therapeutics Announces Academic Collaboration with The University of Texas at Austin | NASDAQ:PTIE | Pain Therapeutics, Inc. (MM) |
| 16/01/2019 | 12:00 | GlobeNewswire Inc. | Pain Therapeutics Awarded $1.5 Million Research Grant by National Institutes of Health | NASDAQ:PTIE | Pain Therapeutics, Inc. (MM) |
| 07/01/2019 | 11:30 | GlobeNewswire Inc. | Pain Therapeutics Announces Two New Peer-Reviewed Publications for REMOXY | NASDAQ:PTIE | Pain Therapeutics, Inc. (MM) |
| 18/12/2018 | 21:00 | GlobeNewswire Inc. | Pain Therapeutics Announces Filing of Registration Statement on SEC Form S-1 | NASDAQ:PTIE | Pain Therapeutics, Inc. (MM) |
| 18/12/2018 | 20:29 | Edgar (US Regulatory) | Securities Registration Statement (s-1) | NASDAQ:PTIE | Pain Therapeutics, Inc. (MM) |
| 06/12/2018 | 10:30 | GlobeNewswire Inc. | Pain Therapeutics Announces Initiation of a Phase II Study in Alzheimer’s Disease | NASDAQ:PTIE | Pain Therapeutics, Inc. (MM) |
| 12/11/2018 | 10:30 | GlobeNewswire Inc. | Pain Therapeutics Appeals FDA Decision on REMOXY | NASDAQ:PTIE | Pain Therapeutics, Inc. (MM) |
| 01/11/2018 | 17:34 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:PTIE | Pain Therapeutics, Inc. (MM) |
| 31/10/2018 | 17:04 | Edgar (US Regulatory) | Initial Statement of Beneficial Ownership (3) | NASDAQ:PTIE | Pain Therapeutics, Inc. (MM) |
| 30/10/2018 | 17:44 | Edgar (US Regulatory) | Quarterly Report (10-q) | NASDAQ:PTIE | Pain Therapeutics, Inc. (MM) |
| 29/10/2018 | 17:05 | GlobeNewswire Inc. | Pain Therapeutics Reports Third Quarter 2018 Financial Results | NASDAQ:PTIE | Pain Therapeutics, Inc. (MM) |
| 23/10/2018 | 08:30 | GlobeNewswire Inc. | Pain Therapeutics Invites you to Join a Conference Call on Third Quarter 2018 Financial Results | NASDAQ:PTIE | Pain Therapeutics, Inc. (MM) |
| 11/10/2018 | 08:30 | GlobeNewswire Inc. | Pain Therapeutics Announces Appointment of Chief Financial Officer | NASDAQ:PTIE | Pain Therapeutics, Inc. (MM) |
| 04/10/2018 | 08:30 | GlobeNewswire Inc. | Pain Therapeutics Announces $3.5 Million NIH Grant Award to Study Alzheimer’s Disease | NASDAQ:PTIE | Pain Therapeutics, Inc. (MM) |
| 02/10/2018 | 20:48 | GlobeNewswire Inc. | Pain Therapeutics Announces Investor Call to Provide Strategic Update | NASDAQ:PTIE | Pain Therapeutics, Inc. (MM) |
| 30/08/2018 | 13:16 | Edgar (US Regulatory) | Small Company Offering and Sale of Securities Without Registration (d) | NASDAQ:PTIE | Pain Therapeutics, Inc. (MM) |
| 17/08/2018 | 18:15 | GlobeNewswire Inc. | Pain Therapeutics Announces Closing of $11.3 Million Registered Direct Offering | NASDAQ:PTIE | Pain Therapeutics, Inc. (MM) |
| 17/08/2018 | 13:46 | Edgar (US Regulatory) | Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) | NASDAQ:PTIE | Pain Therapeutics, Inc. (MM) |
| 16/08/2018 | 08:00 | GlobeNewswire Inc. | Pain Therapeutics Announces $11.3 Million Registered Direct Offering Priced At-the-Market | NASDAQ:PTIE | Pain Therapeutics, Inc. (MM) |
| 16/08/2018 | 07:03 | Edgar (US Regulatory) | Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) | NASDAQ:PTIE | Pain Therapeutics, Inc. (MM) |
| 15/08/2018 | 09:00 | GlobeNewswire Inc. | Pain Therapeutics Awarded $3.2 Million NIH Grant to Study Alzheimer’s Disease | NASDAQ:PTIE | Pain Therapeutics, Inc. (MM) |